Nasdaq futures lag on global chip weakness
Seeking Alpha News (Thu, 16-Jul 4:01 AM ET)
UnitedHealth eyes another strong quarter as analysts see improving medical cost trends
Seeking Alpha News (Wed, 15-Jul 10:12 AM ET)
The Cigna Group's Second Quarter 2026 Earnings Release Details
PRNewswire (Tue, 7-Jul 6:00 AM ET)
PRNewswire (Wed, 1-Jul 8:01 AM ET)
PRNewswire (Thu, 25-Jun 10:15 AM ET)
PRNewswire (Tue, 23-Jun 10:00 AM ET)
The Cigna Group Announces Appearance at the BofA Securities 2026 Health Care Conference
PRNewswire (Wed, 13-May 6:00 AM ET)
Globe Newswire (Tue, 12-May 4:20 PM ET)
The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 Outlook
PRNewswire (Thu, 30-Apr 6:00 AM ET)
The Cigna Group, Leading Health Plans Advance Work to Simplify Prior Authorization
PRNewswire (Fri, 24-Apr 9:05 AM ET)
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
Cigna Group trades on the NYSE stock market under the symbol CI.
As of July 16, 2026, CI stock price declined to $283.82 with 3,077,512 million shares trading.
CI has a beta of 0.35, meaning it tends to be less sensitive to market movements. CI has a correlation of 0.02 to the broad based SPY ETF.
CI has a market cap of $75.07 billion. This is considered a Large Cap stock.
Last quarter Cigna Group reported $69 billion in Revenue and $7.79 earnings per share. This beat revenue expectation by $2 billion and exceeded earnings estimates by $.18.
In the last 3 years, CI traded as high as $370.83 and as low as $239.51.
The top ETF exchange traded funds that CI belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
CI has underperformed the market in the last year with a return of -4.1%, while the SPY ETF gained +21.9%. In the last 3 month period, CI fell short of the market, returning +6.2%, while SPY returned +7.5%. However, in the most recent 2 weeks CI has outperformed the stock market by returning +2.4%, while SPY returned +0.7%.
CI support price is $292.46 and resistance is $303.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CI shares will trade within this expected range on the day.